Abstract OP0085 Table 1

Mean ACR-N and change in TSS at weeks 30, 54, and 102 in ACR20 non-responders at week 30

	Placebo	3 mg/kg q 8 wks	3 mg/kg q 4 wks	10 mg/kg q 8 wks	10 mg/kg q 4 wks	Total infliximab

Number of ACR 20	63	39	42	41	32	154
ACR-N at Week 30	1.2	2.3	2.9	3.5*	3.3*	3.0*
ACR-N at Week 54	2.4	9.4*	9.0*	17.1*	17.8*	13.1*
ACR-N at Week 102	3.3	12.2*	6.7	18.7*	10.1*	11.9*
Change in TSS at Week 30	5.1	2.3	0.8*	<0.1*	0.5*	0.9*
Change in TSS at Week 54	7.2	3.0*	1.9*	0.2*	0.3*	1.3*
Change in TSS at Week 102	13.5	3.7	1.8*	0.9*	-0.8*	1.4*